Get the Stockscreener App
7.2014
1.09%
-0.0796
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Forecast
The Quoin Pharmaceuticals Ltd Adr (QNRX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $11.56, representing a +60.51% increase from the current price of $7.2014. The highest analyst price target is $11.79, and the lowest is $11.32.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month QNRX Price Target
Average 5.9498
(-17.38% Downside)
Is Quoin Pharmaceuticals Ltd Adr (QNRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 39.85 | Neutral |
| STOCH(9,6) | 46.29 | Neutral |
| STOCHRSI(14) | 70.94 | Neutral |
| MACD(12,26) | -0.3274 | Buy |
| ADX(14) | 12.55 | Neutral |
| William %R | -65.31 | Neutral |
| CCI(14) | -3.703 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
7.182
Sell
|
7.2307
Sell
|
| MA20 |
7.4012
Sell
|
7.4628
Sell
|
| MA50 |
8.2392
Sell
|
7.9468
Sell
|
| MA100 |
7.8223
Sell
|
8.9755
Sell
|
| MA200 |
12.70
Sell
|
11.84
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, QNRX could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 10 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on QNRX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 39.85 indicates that QNRX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 46.29 indicates that QNRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 70.94 indicates that QNRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 12.55 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -3.703 indicates that QNRX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term QNRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Quoin Pharmaceuticals Ltd Adr financial reports and earnings history, Quoin Pharmaceuticals Ltd Adr (QNRX) stock could reach $52.57 by 2030, $33.77 by 2040 and $138.39 by 2050. See the projected annual prices until 2050 of the Quoin Pharmaceuticals Ltd Adr stock below:
- Quoin Pharmaceuticals Ltd Adr (QNRX) is expected to reach an average price of $7.1813 in 2035, with a high prediction of $7.8508 and a low estimate of $7.1877. This indicates an $-0.28% rise from the last recorded price of $7.2014.
- Quoin Pharmaceuticals Ltd Adr (QNRX) stock is projected to chart a bullish course in 2040, with an average price target of $31.64, representing an $339.37% surge from its current level. The forecast ranges from a conservative $31.86 to a sky-high $33.77.
- Our analysts predict Quoin Pharmaceuticals Ltd Adr (QNRX) to jump 974.66% by 2045, soaring from $77.42 to an average price of $77.39, potentially reaching $81.33. While $77.42 is the low estimate, the potential upside is significant.
- Quoin Pharmaceuticals Ltd Adr (QNRX) stock is expected to climb by 2050, reaching an average of $133.62, a $1,755% jump from its current level. However, a wide range of estimates exists, with high and low targets of $138.39 and $133.66, respectively, highlighting the market's uncertainty.
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Year by Year Forecast
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Price Forecast for 2025
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) is expected to reach an average price of $11.72 in 2025, with a high prediction of $13.97 and a low estimate of $9.4783. This indicates an +62.78% rise from the last recorded price of $7.2014.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| September, 2025 | $11.65 | $11.32 | $11.79 | +61.76% |
| October, 2025 | $10.91 | $10.92 | $11.43 | +51.54% |
| November, 2025 | $10.23 | $10.26 | $10.64 | +42.00% |
| December, 2025 | $9.4384 | $9.4783 | $9.9573 | +31.06% |
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Price Forecast for 2026
The predicted value for Quoin Pharmaceuticals Ltd Adr (QNRX) in 2026 is set at an average of $4.637. Estimates vary from a peak of $9.2393 to a trough of $0.0348, indicating an -35.61% surge from the present price of $7.2014.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $8.7402 | $8.7605 | $9.2393 | +21.37% |
| February, 2026 | $1.0628 | $1.6928 | $8.5717 | -85.24% |
| March, 2026 | $2.615 | $0.9783 | $1.88 | -63.69% |
| April, 2026 | $1.5878 | $1.7028 | $1.9906 | -77.95% |
| May, 2026 | $2.4951 | $2.2384 | $2.1096 | -65.35% |
| June, 2026 | $1.3374 | $1.6761 | $1.8507 | -81.43% |
| July, 2026 | $0.4348 | $0.1047 | $0.9585 | -93.96% |
| August, 2026 | $0.5976 | $0.1419 | $0.9826 | -91.70% |
| September, 2026 | $0.0848 | $0.0348 | $1.187 | -98.82% |
| October, 2026 | $0.2475 | $0.0436 | $0.4035 | -96.56% |
| November, 2026 | $1.2127 | $0.0931 | $3.8458 | -83.16% |
| December, 2026 | $0.6377 | $0.6575 | $1.0055 | -91.15% |
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Quoin Pharmaceuticals Ltd Adr (QNRX) is $16.68, with a high forecast of $33.21 and a low forecast of $0.1461. This indicates an +131.62% increase from the last price of $7.2014.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $23.33 | $0.1461 | $13.58 | +223.96% |
| February, 2027 | $30.26 | $26.50 | $26.01 | +320.25% |
| March, 2027 | $28.24 | $28.90 | $28.58 | +292.21% |
| April, 2027 | $25.30 | $30.76 | $30.34 | +251.38% |
| May, 2027 | $25.74 | $25.52 | $24.99 | +257.41% |
| June, 2027 | $30.97 | $27.83 | $29.12 | +330.05% |
| July, 2027 | $31.59 | $31.75 | $31.16 | +338.68% |
| August, 2027 | $33.76 | $31.58 | $33.21 | +368.85% |
| September, 2027 | $31.32 | $30.68 | $31.38 | +334.90% |
| October, 2027 | $30.63 | $30.74 | $30.87 | +325.38% |
| November, 2027 | $30.22 | $30.96 | $30.99 | +319.61% |
| December, 2027 | $30.58 | $30.07 | $30.11 | +324.69% |
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Price Forecast for 2028
In 2028, Quoin Pharmaceuticals Ltd Adr (QNRX) is projected to reach an average price of $19.48, with a high projection of $29.56 and a low estimate of $9.3967. This indicates an +170.48% rise from the last price of $7.2014.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $29.22 | $29.33 | $29.56 | +305.73% |
| February, 2028 | $27.99 | $28.05 | $28.44 | +288.71% |
| March, 2028 | $26.60 | $26.91 | $27.51 | +269.35% |
| April, 2028 | $25.14 | $25.25 | $26.09 | +249.14% |
| May, 2028 | $24.59 | $24.00 | $24.70 | +241.44% |
| June, 2028 | $23.27 | $23.27 | $24.16 | +223.17% |
| July, 2028 | $21.92 | $21.98 | $22.84 | +204.39% |
| August, 2028 | $20.31 | $20.31 | $21.58 | +182.05% |
| September, 2028 | $18.99 | $19.02 | $19.96 | +163.66% |
| October, 2028 | $17.70 | $17.71 | $18.59 | +145.73% |
| November, 2028 | $9.7978 | $9.3967 | $17.24 | +36.05% |
| December, 2028 | $9.4423 | $9.9323 | $9.8051 | +31.12% |
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Price Forecast for 2029
The 2029 price forecast for Quoin Pharmaceuticals Ltd Adr Stock (QNRX) is $26.40 on average, with a high prediction of $51.79 and a low estimate of $1.0004. This represents an +266.55% increase from the previous price of $7.2014.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $9.3979 | $8.8057 | $8.8635 | +30.50% |
| February, 2029 | $8.0024 | $8.0024 | $8.7192 | +11.12% |
| March, 2029 | $6.457 | $7.057 | $7.2636 | -10.34% |
| April, 2029 | $4.6715 | $4.8604 | $5.6881 | -35.13% |
| May, 2029 | $3.516 | $3.697 | $4.2437 | -51.18% |
| June, 2029 | $3.3416 | $3.4116 | $3.3194 | -53.60% |
| July, 2029 | $2.576 | $2.7561 | $2.7528 | -64.23% |
| August, 2029 | $2.7318 | $2.3023 | $3.0108 | -62.07% |
| September, 2029 | $1.7288 | $1.7634 | $2.374 | -75.99% |
| October, 2029 | $45.13 | $1.0004 | $44.50 | +526.72% |
| November, 2029 | $51.78 | $50.64 | $51.79 | +619.09% |
| December, 2029 | $53.44 | $51.79 | $50.69 | +642.03% |
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Price Forecast for 2030
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) is expected to reach an average price of $46.36 in 2030, with a high forecast of $52.57 and a low forecast of $40.15. This signifies an +543.75% surge from the last price of $7.2014.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $46.47 | $47.09 | $52.57 | +545.29% |
| February, 2030 | $47.50 | $47.48 | $46.37 | +559.55% |
| March, 2030 | $52.98 | $49.38 | $51.15 | +635.74% |
| April, 2030 | $51.11 | $51.18 | $51.04 | +609.73% |
| May, 2030 | $48.67 | $49.46 | $52.32 | +575.84% |
| June, 2030 | $49.90 | $49.84 | $49.14 | +592.94% |
| July, 2030 | $48.62 | $48.37 | $48.08 | +575.20% |
| August, 2030 | $47.00 | $46.87 | $48.12 | +552.66% |
| September, 2030 | $45.91 | $46.27 | $46.58 | +537.48% |
| October, 2030 | $43.66 | $43.68 | $45.38 | +506.28% |
| November, 2030 | $41.95 | $42.01 | $43.05 | +482.49% |
| December, 2030 | $40.08 | $40.15 | $41.37 | +456.62% |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):